Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma
PURPOSETo investigate the influence of personality traits, depression, and training on objectively measured adherence to once-daily prostaglandin analog medication. METHODSAdherence was measured with the Travalert Dosing Aid on 58 consecutive, regularly followed-up glaucoma patients already on self-...
Gespeichert in:
| Veröffentlicht in: | Journal of glaucoma 2009-04, Vol.18 (4), p.288-292 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 292 |
|---|---|
| container_issue | 4 |
| container_start_page | 288 |
| container_title | Journal of glaucoma |
| container_volume | 18 |
| creator | Holló, Gábor Kóthy, Péter Géczy, Anna Vargha, Péter |
| description | PURPOSETo investigate the influence of personality traits, depression, and training on objectively measured adherence to once-daily prostaglandin analog medication.
METHODSAdherence was measured with the Travalert Dosing Aid on 58 consecutive, regularly followed-up glaucoma patients already on self-administered travoprost. Before the 3-month data-collection period all patients received training on use of the device. Psychologic characteristics were measured using the State-Trait Anxiety Inventory, Eysenck Personality Questionnaire, and Beck Hopeless Scale and Depression Inventory. An adherent day was defined as travoprost instillation at 9 PM ±2 hours.
RESULTSAdherence was 77% for the total period. Social desirability was higher than normal (U test, P |
| doi_str_mv | 10.1097/IJG.0b013e31818456b9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67140705</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67140705</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3505-f03f2017be4e006a08fc6346d3842e9b0fccf7d99733976c57d0d1a70bab41db3</originalsourceid><addsrcrecordid>eNpdkEFv1DAQhS0EoqXwDxDyiVNTxnESx8dVgaWoaHsoErfIsSddF2-82A7VSvx4BnWlShzsGVvvfZp5jL0VcCFAqw9XX9cXMIKQKEUv-qbtRv2MnYpWdlXTix_PqYdWVdDX-oS9yvkeoIa6Fi_ZidCya-k6ZX9uMOU4m-DLgd8m40s-5x9xnzBnH-dzbmbHN-M92uJ_Yzjwb2jyktDxldtiwtkiL5FvqFbOeBLcpJiLuQtk9DNfETrekct5awoROX2ug1ls3JnX7MVkQsY3x3rGvn_-dHv5pbrerK8uV9eVlS201QRyqkGoERsE6Az0k-1k0znZNzXqESZrJ-W0VlJq1dlWOXDCKBjN2Ag3yjP2_pG7T_HXgrkMO58tBpoR45KHTokGFLQkbB6FlpbICadhn_zOpMMgYPiX-kCpD_-nTrZ3R_4y7tA9mY4xP3EfYigU-M-wPGAatmhC2Q5ASwmh-6oG0NDQs6JD4_wFw4KPiw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67140705</pqid></control><display><type>article</type><title>Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Holló, Gábor ; Kóthy, Péter ; Géczy, Anna ; Vargha, Péter</creator><creatorcontrib>Holló, Gábor ; Kóthy, Péter ; Géczy, Anna ; Vargha, Péter</creatorcontrib><description>PURPOSETo investigate the influence of personality traits, depression, and training on objectively measured adherence to once-daily prostaglandin analog medication.
METHODSAdherence was measured with the Travalert Dosing Aid on 58 consecutive, regularly followed-up glaucoma patients already on self-administered travoprost. Before the 3-month data-collection period all patients received training on use of the device. Psychologic characteristics were measured using the State-Trait Anxiety Inventory, Eysenck Personality Questionnaire, and Beck Hopeless Scale and Depression Inventory. An adherent day was defined as travoprost instillation at 9 PM ±2 hours.
RESULTSAdherence was 77% for the total period. Social desirability was higher than normal (U test, P<0.0001). Seven patients (12.1%) showed mild-to-moderate depression, which was not significantly associated with decreased adherence (Kruskal-Wallis test, P=0.071). Severity of glaucoma, number of ocular and systemic medications, satisfaction with the recording device, and socio-economic characteristics had no influence on adherence.
CONCLUSIONSObjectively measured adherence to once-daily prostaglandin analog medication was good, and not influenced by treatment characteristics or patient factors including mild-to-moderate depression. The elevated social desirability suggests that self-reported adherence is not a reliable measure of adherence in glaucoma.</description><identifier>ISSN: 1057-0829</identifier><identifier>EISSN: 1536-481X</identifier><identifier>DOI: 10.1097/IJG.0b013e31818456b9</identifier><identifier>PMID: 19365193</identifier><language>eng</language><publisher>United States: Lippincott Williams & Wilkins, Inc</publisher><subject>Aged ; Antihypertensive Agents - administration & dosage ; Anxiety Disorders - psychology ; Cloprostenol - administration & dosage ; Cloprostenol - analogs & derivatives ; Depressive Disorder - psychology ; Drug Monitoring - instrumentation ; Female ; Glaucoma - drug therapy ; Humans ; Intraocular Pressure - physiology ; Male ; Medication Adherence - psychology ; Ocular Hypertension - drug therapy ; Patient Education as Topic ; Personality Disorders - psychology ; Surveys and Questionnaires ; Travoprost</subject><ispartof>Journal of glaucoma, 2009-04, Vol.18 (4), p.288-292</ispartof><rights>2009 Lippincott Williams & Wilkins, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3505-f03f2017be4e006a08fc6346d3842e9b0fccf7d99733976c57d0d1a70bab41db3</citedby><cites>FETCH-LOGICAL-c3505-f03f2017be4e006a08fc6346d3842e9b0fccf7d99733976c57d0d1a70bab41db3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19365193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Holló, Gábor</creatorcontrib><creatorcontrib>Kóthy, Péter</creatorcontrib><creatorcontrib>Géczy, Anna</creatorcontrib><creatorcontrib>Vargha, Péter</creatorcontrib><title>Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma</title><title>Journal of glaucoma</title><addtitle>J Glaucoma</addtitle><description>PURPOSETo investigate the influence of personality traits, depression, and training on objectively measured adherence to once-daily prostaglandin analog medication.
METHODSAdherence was measured with the Travalert Dosing Aid on 58 consecutive, regularly followed-up glaucoma patients already on self-administered travoprost. Before the 3-month data-collection period all patients received training on use of the device. Psychologic characteristics were measured using the State-Trait Anxiety Inventory, Eysenck Personality Questionnaire, and Beck Hopeless Scale and Depression Inventory. An adherent day was defined as travoprost instillation at 9 PM ±2 hours.
RESULTSAdherence was 77% for the total period. Social desirability was higher than normal (U test, P<0.0001). Seven patients (12.1%) showed mild-to-moderate depression, which was not significantly associated with decreased adherence (Kruskal-Wallis test, P=0.071). Severity of glaucoma, number of ocular and systemic medications, satisfaction with the recording device, and socio-economic characteristics had no influence on adherence.
CONCLUSIONSObjectively measured adherence to once-daily prostaglandin analog medication was good, and not influenced by treatment characteristics or patient factors including mild-to-moderate depression. The elevated social desirability suggests that self-reported adherence is not a reliable measure of adherence in glaucoma.</description><subject>Aged</subject><subject>Antihypertensive Agents - administration & dosage</subject><subject>Anxiety Disorders - psychology</subject><subject>Cloprostenol - administration & dosage</subject><subject>Cloprostenol - analogs & derivatives</subject><subject>Depressive Disorder - psychology</subject><subject>Drug Monitoring - instrumentation</subject><subject>Female</subject><subject>Glaucoma - drug therapy</subject><subject>Humans</subject><subject>Intraocular Pressure - physiology</subject><subject>Male</subject><subject>Medication Adherence - psychology</subject><subject>Ocular Hypertension - drug therapy</subject><subject>Patient Education as Topic</subject><subject>Personality Disorders - psychology</subject><subject>Surveys and Questionnaires</subject><subject>Travoprost</subject><issn>1057-0829</issn><issn>1536-481X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkEFv1DAQhS0EoqXwDxDyiVNTxnESx8dVgaWoaHsoErfIsSddF2-82A7VSvx4BnWlShzsGVvvfZp5jL0VcCFAqw9XX9cXMIKQKEUv-qbtRv2MnYpWdlXTix_PqYdWVdDX-oS9yvkeoIa6Fi_ZidCya-k6ZX9uMOU4m-DLgd8m40s-5x9xnzBnH-dzbmbHN-M92uJ_Yzjwb2jyktDxldtiwtkiL5FvqFbOeBLcpJiLuQtk9DNfETrekct5awoROX2ug1ls3JnX7MVkQsY3x3rGvn_-dHv5pbrerK8uV9eVlS201QRyqkGoERsE6Az0k-1k0znZNzXqESZrJ-W0VlJq1dlWOXDCKBjN2Ag3yjP2_pG7T_HXgrkMO58tBpoR45KHTokGFLQkbB6FlpbICadhn_zOpMMgYPiX-kCpD_-nTrZ3R_4y7tA9mY4xP3EfYigU-M-wPGAatmhC2Q5ASwmh-6oG0NDQs6JD4_wFw4KPiw</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Holló, Gábor</creator><creator>Kóthy, Péter</creator><creator>Géczy, Anna</creator><creator>Vargha, Péter</creator><general>Lippincott Williams & Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200904</creationdate><title>Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma</title><author>Holló, Gábor ; Kóthy, Péter ; Géczy, Anna ; Vargha, Péter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3505-f03f2017be4e006a08fc6346d3842e9b0fccf7d99733976c57d0d1a70bab41db3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>Antihypertensive Agents - administration & dosage</topic><topic>Anxiety Disorders - psychology</topic><topic>Cloprostenol - administration & dosage</topic><topic>Cloprostenol - analogs & derivatives</topic><topic>Depressive Disorder - psychology</topic><topic>Drug Monitoring - instrumentation</topic><topic>Female</topic><topic>Glaucoma - drug therapy</topic><topic>Humans</topic><topic>Intraocular Pressure - physiology</topic><topic>Male</topic><topic>Medication Adherence - psychology</topic><topic>Ocular Hypertension - drug therapy</topic><topic>Patient Education as Topic</topic><topic>Personality Disorders - psychology</topic><topic>Surveys and Questionnaires</topic><topic>Travoprost</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Holló, Gábor</creatorcontrib><creatorcontrib>Kóthy, Péter</creatorcontrib><creatorcontrib>Géczy, Anna</creatorcontrib><creatorcontrib>Vargha, Péter</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of glaucoma</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Holló, Gábor</au><au>Kóthy, Péter</au><au>Géczy, Anna</au><au>Vargha, Péter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma</atitle><jtitle>Journal of glaucoma</jtitle><addtitle>J Glaucoma</addtitle><date>2009-04</date><risdate>2009</risdate><volume>18</volume><issue>4</issue><spage>288</spage><epage>292</epage><pages>288-292</pages><issn>1057-0829</issn><eissn>1536-481X</eissn><abstract>PURPOSETo investigate the influence of personality traits, depression, and training on objectively measured adherence to once-daily prostaglandin analog medication.
METHODSAdherence was measured with the Travalert Dosing Aid on 58 consecutive, regularly followed-up glaucoma patients already on self-administered travoprost. Before the 3-month data-collection period all patients received training on use of the device. Psychologic characteristics were measured using the State-Trait Anxiety Inventory, Eysenck Personality Questionnaire, and Beck Hopeless Scale and Depression Inventory. An adherent day was defined as travoprost instillation at 9 PM ±2 hours.
RESULTSAdherence was 77% for the total period. Social desirability was higher than normal (U test, P<0.0001). Seven patients (12.1%) showed mild-to-moderate depression, which was not significantly associated with decreased adherence (Kruskal-Wallis test, P=0.071). Severity of glaucoma, number of ocular and systemic medications, satisfaction with the recording device, and socio-economic characteristics had no influence on adherence.
CONCLUSIONSObjectively measured adherence to once-daily prostaglandin analog medication was good, and not influenced by treatment characteristics or patient factors including mild-to-moderate depression. The elevated social desirability suggests that self-reported adherence is not a reliable measure of adherence in glaucoma.</abstract><cop>United States</cop><pub>Lippincott Williams & Wilkins, Inc</pub><pmid>19365193</pmid><doi>10.1097/IJG.0b013e31818456b9</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1057-0829 |
| ispartof | Journal of glaucoma, 2009-04, Vol.18 (4), p.288-292 |
| issn | 1057-0829 1536-481X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67140705 |
| source | MEDLINE; Journals@Ovid Complete |
| subjects | Aged Antihypertensive Agents - administration & dosage Anxiety Disorders - psychology Cloprostenol - administration & dosage Cloprostenol - analogs & derivatives Depressive Disorder - psychology Drug Monitoring - instrumentation Female Glaucoma - drug therapy Humans Intraocular Pressure - physiology Male Medication Adherence - psychology Ocular Hypertension - drug therapy Patient Education as Topic Personality Disorders - psychology Surveys and Questionnaires Travoprost |
| title | Personality Traits, Depression, and Objectively Measured Adherence to Once-daily Prostaglandin Analog Medication in Glaucoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Personality%20Traits,%20Depression,%20and%20Objectively%20Measured%20Adherence%20to%20Once-daily%20Prostaglandin%20Analog%20Medication%20in%20Glaucoma&rft.jtitle=Journal%20of%20glaucoma&rft.au=Holl%C3%B3,%20G%C3%A1bor&rft.date=2009-04&rft.volume=18&rft.issue=4&rft.spage=288&rft.epage=292&rft.pages=288-292&rft.issn=1057-0829&rft.eissn=1536-481X&rft_id=info:doi/10.1097/IJG.0b013e31818456b9&rft_dat=%3Cproquest_cross%3E67140705%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67140705&rft_id=info:pmid/19365193&rfr_iscdi=true |